Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.20.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Concentration Risk [Line Items]    
Revenues $ 88,489 $ 90,202
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 68,406 70,399
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 20,083 $ 19,803